A study of older adults showed that 6% had depression, with higher prevalences in certain groups, including women, those who ...

I did the right thing and reported symptoms of a psychotic relapse to my provider. Contacting your provider immediately is so ...

The U.S. Food and Drug Administration late Thursday approved a new kind of drug to treat schizophrenia, a breakthrough after 70 years of incremental innovation that appears to avoid side effects ...

The broad availability of such a large number of antipsychotics raises the question of what additional benefit these three new antipsychotics may bring. On the one hand, the availability of three ...

About a third of people with schizophrenia are resistant to conventional antipsychotic treatment. The current "pharmaceutical arsenal is limited". Clinical trials for new medications are expensive ...

Robust 359 patient trial met primary endpoint with statistically significant reduction in PANSS total score at all dose levels compared to ...

A new study by researchers at the University of Waterloo demonstrates that antipsychotic medications significantly worsened ...

A disproportionately high number of people admitted to long-term care facilities during the COVID-19 pandemic's first year were on antipsychotic medications, recently published Brock-led research ...

The FDA approval of Alkermes' new antipsychotic drug Lybalvi couldn't have gone any better for the company, but it could still face a big challenge positioning the new drug in the highly ...

New admissions were grouped into categories based on the referral ... Using data from the Canadian Institute for Health ...

Opens in a new tab or window In a review of studies involving children and adolescents taking antipsychotics, a new systematic literature review found rates of TD between 5% and 20%. Risk factors ...

A new evidence-based guideline recommends prescribing metformin when initiating antipsychotic treatment to help mitigate weight gain in certain instances. There is “good evidence” that ...